ArticleScientific reports2025
Short-term and patient-reported outcomes of laser hemorrhoidoplasty plus excisional hemorrhoidectomy for the treatment of grade IV hemorrhoid.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Laser hemorrhoidoplasty (LHP) is mainly used for symptomatic grade I-III hemorrhoid. Only a few studies have reported the application of lasers for grade IV hemorrhoids. The study aimed to compare LHP plus excisional hemorrhoidectomy (EH) and LigaSure hemorrhoidectomy in terms of short-term and patient-reported outcomes for the treatment of grade IV hemorrhoids. Patients with grade IV hemorrhoid undergoing LHP plus EH between June 2022 and May 2024 were retrospectively included and historically compared with patients undergoing LigaSure hemorrhoidectomy between January 2019 to May 2022 at a regional hospital. The primary outcome was the surgical results and 30-day complications. The secondary outcome was the postoperative results including pain score by using visual analogue scale (VAS) score and patient-reported outcomes by using the Hemorrhoidal Disease Symptom Score and Short Health Scale
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.